Gene therapy for a subtype of eye disease approved in the Netherlands

From 2021, patients suffering from RPE65-associated retinal disease will be able to be treated in three UMCs of the Netherlands.

https://www.radboudumc.nl/nieuws/2020/gentherapie-voor-zeldzame-oogziekte-vergoed